Keyword: Hospira

News

Biosimilars Seen as a $3.7 billion Drug Market by 2015

29.03.2011 - The worldwide market for copies of biotech medicines will grow to $3.7 billion by 2015, from just $243 million in 2010, as a raft of branded drugs lose patent cover, according to...

News

Novartis Moves to Stop Execution Drug Reaching US

11.02.2011 - Novartis and its Sandoz unit, maker of a generic version of an anaesthetic used in lethal injections in the United States, have taken steps to try to stop the drug ending up in the...

News

Hospira To Stop Making Sodium Thiopental

24.01.2011 - An anesthetic used in lethal injections will no longer be made by its only U.S. manufacturer because the company does not want it to be used in executions, forcing states that...

News

Fresenius Could Be in the Mood for Acquisitions

08.12.2010 - German healthcare conglomerate Fresenius could return to the acquisition trail after investors' response to its latest deal swung from cool to enthusiastic. Two people with...

News

Biosimilar Antibodies: EMA Adopts Guideline

22.11.2010 - European regulators adopted a new guideline on so-called biosimilar antibody drugs on Friday, paving the way for cheaper copies of multi-billion-dollar medicines for cancer and...

News

Biosimilar Antibodies: EU Likely to Be Cautious

17.11.2010 - European regulators are expected to adopt a conservative stance this week when they set rules for allowing copies of antibody drugs, used to fight cancer, rheumatoid arthritis and...